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BACtein of equine herpesvirus 1 (EHV-1), is not a DNA-binding protein, but interacts
with the sole immediate-early protein (IEP) to increase both IEP site-speciﬁc DNA-binding and IEP-mediated
trans-activation of EHV-1 promoters. To investigate the biological properties of IR4 and ascertain whether
this regulatory protein is essential for virus growth, bacterial artiﬁcial chromosome methods were employed
to generate an IR4-null EHV-1. The IR4 gene was dispensable for EHV-1 growth in non-immortalized equine
NBL-6 cells, but virus replication was delayed and was reduced by greater than 10-fold. In addition,
replication of the IR4 mutant was abrogated in all other cell types tested, including equine ETCC tumor cells
and cells of mouse, rabbit, monkey, and human origin. Further, in contrast to the highly pathogenic parent
virus, the IR4 deletion mutant failed to cause disease in the CBA mouse as judged by assessing body weight
and clinical signs and was unable to replicate in the murine lung. To deﬁne the nature of the block in the
replication of the IR4-null virus, molecular analyses were carried out in RK-13 rabbits' cells infected with the
IR4-deleted virus and revealed that: 1) the synthesis of the sole IEP was not inhibited; 2) the synthesis of
early viral proteins examined was either not affected or was delayed to late times; 3) viral DNA replication
was inhibited by more than 99.9%; and 4) synthesis of essential late proteins such as glycoprotein D and
glycoprotein K was prevented. These ﬁndings indicate that the IR4 protein is required for EHV-1 DNA
replication in non-permissive cells, and, like its homologues in other alphaherpesviruses, contributes a
function required for virus replication in a variety of cell types.
© 2008 Elsevier Inc. All rights reserved.Introduction
Six viral proteins play major roles in the regulation of EHV-1 gene
expression: the sole immediate-early protein (IEP), four early proteins
(IR2P, EICP0P, UL5P [EICP27], and IR4 [EICP22]), and the late tegument
protein, α-trans-inducing factor (ETIF) (O'Callaghan and Osterrieder,
2008). The 1487aa IEP is the major regulatory protein of EHV-1 and
serves a bifunctional regulatory role by: i) independently trans-
activating EHV-1 early promoters (Caughman et al., 1985; Harty et
al., 1990; Smith et al., 1992, 1994); and ii) trans-repressing its own
promoter (Harty and O'Callaghan, 1991; Smith et al., 1994) and some
late promoters (Kim et al.,1999). The IE gene is further regulated by the
IR2 protein, an amino-terminal truncated (323-1487aa) version of the
IEP encoded within the IE gene (Harty and O'Callaghan, 1991;
Caughman et al., 1995; Kim et al., 2006) and by the IR3 RNA that is
antisense to the IE transcript (Holden et al.,1992a; Ahn et al., 2007) The
IEP also functions in concert with EHV-1 early regulatory proteins IR4.
l rights reserved.(Kim et al., 1997; Derbigny et al., 2000, 2002) and UL5P (Smith et al.,
1993; Zhao et al., 1995; Albrecht et al., 2004, 2005) as well as with
cellular transcription factors TATA box-binding protein (TBP) and TFIIB
(Jang et al., 2001; Albrecht et al., 2003; Kim et al., 2003; Kim and
O'Callaghan, unpublished results) and the nucleolar shuttle protein,
EAP (Kim et al., 2001). Several IEP functional domains have been
characterized, including the trans-activation domain (Smith et al.,
1994; Buczynski et al., 1999), a site-speciﬁc DNA binding domain (Kim
et al., 1995), a nuclear localization signal (NLS; Smith et al., 1995), a
serine-rich tract (SRT; Kim et al., 2001), and a TFIIB-binding domain
(Jang et al., 2001). Characterization of 17 EHV-1 IE mutants revealed
that these functional domains are essential for virus replication
(Buczynski et al., 2005).
IR4 is an early 293aa protein that in concert with the IE or the
EICP0 protein signiﬁcantly enhances the trans-activation of early viral
promoters (Holden et al., 1992b, 1994, 1995; Kim et al., 1997). While
not a DNA-binding protein, IR4 greatly enhances the DNA-binding
activity of the IEP, and is able to restore the DNA-binding ability of
some IEP mutants (Kim et al., 1995). Additionally, IR4 interacts with
itself to form dimers and higher-ordered complexes (Derbigny et al.,
2000). The exact mechanisms by which IR4 regulates viral gene
expression, however, remain poorly deﬁned.
Table 1
Virus genotypes
Name Genotype
RacL11 Wild-type virus
RacL11BDΔEUs4 RacL11 derived from BAC DNA, EUs4 deleted in the
construction of the BAC
RacL11BD RacL11 derived from BAC DNA, EUs4 restored
RacL11ΔIR4ΔEUs4 RacL11 derived from BAC DNA, ΔIR4, EUs4 deleted in
the construction of the BAC
RacL11ΔIR4, IR4-/- RacL11 derived from BAC DNA, ΔIR4, EUs4 restored
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lytic infection yet may trans-repress EHV-1 genes during persistent
infection mediated by defective interfering particles (DIP) (Ebner and
O'Callaghan, 2006, 2008). The recombination events that generate
DIP genomes produce one of two unique hybrid genes consisting of 5′
sequences of IR4 fused to 3′ sequences of UL5 (Baumann et al., 1987;
Yalamanchili et al.,1990; Chen et al.,1996,1999; Ebner and O'Callaghan,
2006; Ebner et al., 2008). Both hybrid proteins (HYB1.0 and HYB2.0) are
produced in large quantities during EHV-1 persistent infection (Chen
et al., 1996, Ebner and O'Callaghan, 2006), and previous studies
demonstrated that the HYB1.0 protein downregulates EHV-1 gene
expression (Chen et al., 1999). Recent work revealed that IR4 residues
within the HYB proteins are necessary for interference with standard
virus replication, a hallmark of persistent infection (Ebner et al., 2008).
To examine the role of the IR4 protein during lytic and persistent
infections, bacterial artiﬁcial chromosome (BAC) technology was used
to delete both copies of the IR4 gene from the highly pathogenic
RacL11 strain of EHV-1. The resulting IR4-null virus (RacL11ΔIR4) was
characterized with regard to replication in diverse cell cultures,
pathogenesis in the murine model, and alterations in the replication
cycle of EHV-1 at the levels of protein production and DNA replication.
Overall, the results reveal that IR4 is essential for EHV-1 replication in
the mouse as well as most cell types and for efﬁcient replication in
equine NBL-6 cells that allow limited growth of the IR4-null virus.
Results
Construction of an EHV-1 IR4 deletion mutant
Our previous studies revealed that IR4 is an auxiliary regulatory
protein that physically interacts with the IE protein and enhances its
ability to trans-activate EHV-1 promoters (Kim et al., 1995, 1997). We
therefore hypothesized that the IR4 protein plays an essential role for
viral replication. To address this hypothesis, the IR4 genes contained
in the terminal and internal repeats of the two isomeric EHV-1
genome were replaced with DNA cassettes harboring kanamycinFig. 1. Conﬁrmation of IR4 deletion mutant BAC. Panel A: BamHI restriction enzyme analysis
deletion. Panels B to D: Southern blot analyses of digested BAC DNAs. Panel E: western blot a
of both the IR4 and EUs4 genes (RacL11ΔIR4ΔEUs4), or EHV-1 RacL11 deleted of EUs4 (RacL1
both IR4 and EUs4 genes (RacL11ΔIR4ΔEUs4), viral DNA lacking IR4 with the EUs4 gene resto
gene restored (RacL11BD), and a control plasmid harboring the EUs4 ORF (pGEXEUs4). Me
described in the Materials and Methods.(KAN) and zeocin (ZEO) antibiotic resistance genes using bacterial
artiﬁcial chromosome techniques (Rudolph et al. 2002). Comparison
of the BamHI restriction enzyme digestion pattern of the RacL11 BAC
to those of the single IR4 knockout and the double IR4 knockout
mutant BAC revealed the appearance of a high molecular weight band
and the loss of a lower molecular weight band in the IR4 mutants,
observations consistent with the predicted genomic changes resulting
from IR4 deletion as noted in Fig. 1A. Southern blot analysis of the
parent BAC genome and the single and double IR4 knockout mutant
BAC genomes indicated that a single copy of the IR4 gene was
successfully replaced by the KAN gene (Fig. 1B and C) and that the
second copy of the IR4 gene was successfully replaced by the ZEO
gene. This was demonstrated by a failure of the IR4 probe to hybridize
to pRacL11ΔIR4 (2×) DNA (Fig. 1B) and the appearance of bands of the
expected size in samples incubated with KAN (Fig. 1C) and ZEO
(Fig.1D) speciﬁc probes. The EUs4 gene, which encodes glycoprotein 2,
was deleted in the construction of the BAC and was restored to
RacL11ΔIR4ΔEUs4 and RacL11BDΔEUs4, creating RacL11ΔIR4 and
RacL11BD, respectively. PCR analysis (Fig. 1F) and DNA sequencing of
the EHV-1/antibiotic resistance cassette junctions (data not shown)
conﬁrmed the insertion sites of the antibiotic resistance genes and the
restoration of EUs4 to both RacL11ΔIR4 and RacL11BD. Growth kinetics
of RacL11BD and wt RacL11 were monitored over a 72 h time course
and found to be indistinguishable (data not shown). Virus genotypes
are summarized in Table 1.of BAC DNA.◂=band added as result of IR4 deletion; ●=band removed as result of IR4
nalysis of extracts of NBL-6 cells infected with EHV-1wt (RacL11), EHV-1 RacL11 deleted
1ΔEUs4). Panel F: PCR ampliﬁcation using primers speciﬁc for EUs4 of viral DNA lacking
red (RacL11ΔIR4), viral DNA lacking EUs4 gene (RacL11ΔEUs4), viral DNA with the EUs4
thods for restriction enzyme digestion, Southern blot analysis, and PCR protocols are
Fig. 2. Plaque morphology and size of wt EHV-1 RacL11, BAC-derived EHV-1 deleted of
the IR4 gene with EUs4 restored (RacL11ΔIR4), and BAC-derived EHV-1 RacL11 with the
EUs4 restored (RacL11BD). Panel A shows representative plaque morphology. Panel B
shows plaque size. Bars represent means of 50 plaques of each virus; error bars
represent standard deviation.
Table 2
Replication of RacL11ΔIR4 and RacL11BD in diverse cell types
Cell Type Virus strain tested
RacL11BD RacL11ΔIR4
L-M 3.83×106±4.71×105 b10
RK13 6.33×106±6.24×105 b10
RK13+pSVIR4 ND 7.7x104±1.04×104
ETCC 2.33×106±8.50×105 b100
NBL-6 2.43×106±2.50×105 1.05×105±1.32×104
Vero 1.58×106±3.12×105 b100
HeLa 1.07×105±1.43×104 b200
Cells were infected at a MOI of 1, and virus titers were determined at various times
post infection by plaque assay on equine NBL-6 cell monolayers. Table shows results at
48 h p.i.
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Transfection of equine ﬁbroblast-like NBL-6 cells with the
RacL11ΔIR4ΔEUs4 construct resulted in the production of viable
virus. Western blot analysis performed using extracts of cells in-
fected with RacL11ΔIR4ΔEUs4 demonstrated that the IR4 protein
was not produced by the IR4-null virus (Fig. 1E). Monolayers of
NBL-6 cells were infected with RacL11ΔIR4, RacL11BD, or RacL11
and incubated to allow for plaque formation. Plaque morphology
(Fig. 2A) and plaque size (Fig. 2B) were not altered in the absence of
IR4 in this equine cell type. Growth kinetics were analyzed by
infecting NBL-6 cells with RacL11BD and RacL11ΔIR4, and virus
production was measured at 3, 6, 12, 18, 24, 36, 48, and 72 h post-
infection. The replication of the IR4 deleted virus was delayed and its
titers were consistently one log or more below those of RacL11BD
in the NBL-6 cells (Fig. 3). Interestingly, studies with equine ETCCFig. 3. Growth kinetics of EHV-1 RacL11 derived from BAC DNA (RacL11BD) and RacL11 delet
24, 36, and 72 h post-infection, and virus was quantitated by standard plaque assay on NBLcells revealed that this tumor cell line failed to support the replication
of RacL11ΔIR4, whereas the parent virus replicated to high titers
(Table 2).
EHV-1 RacL11ΔIR4 is non-pathogenic in the CBA mouse
The effects of the deletion of IR4 on EHV-1 pathogenesis were
assessed by infecting groups of ten CBA mice with sterile medium,
RacL11ΔIR4, or RacL11BD, and the percentage of body weight lost or
gained in comparison to weight at the time of infection was
determined at 24, 48, 72, and 96 h post-infection. No statistical
difference was observed between the mock group and the mice
infected with RacL11ΔIR4, both of which gained close to 10% body
weight by the termination of the experiment. Further, mice infected
with the IR4-null virus failed to exhibit any clinical signs of infection.
Consistent with our previous studies (Smith et al., 2005), mice
infected with RacL11 derived from BAC DNA (RacL11BD) lost
approximately one-ﬁfth of their body weight by the termination of
the experiment (Fig. 4). The in vivo replication capacity of the IR4
deletion mutant was measured by quantifying the concentration of
virus in the lungs of infected mice. Two groups of 20 mice per group
were infected intranasally with 5.0×105 pfu of RacL11ΔIR4 or
RacL11BD, and ﬁve mice from each group were sacriﬁced at 4, 48,
96, and 144 h post-infection. Lungs were harvested from each mouse,
and virus was quantitated by standard plaque assay on equine NBL-6
cells. RacL11ΔIR4 was not recovered at any time point in any of the
mice. In contrast, mice infectedwith RacL11BD produced an average of
4×106 pfu per lung at 48 h post-infection and exhibited clinical signs
of severe disease with mortality rates of 20%–40% (Table 3). Thus, the
deletion of the IR4 gene rendered EHV-1 non-pathogenic in the CBA
mouse model of EHV-1 pathogenesis.
IR4 is essential for EHV-1 replication in non-equine cell types
EHV-1 can be propagated in a large number of cell types
(O'Callaghan and Osterrieder, 2008). The ﬁnding that RacL11ΔIR4ed of IR4 (RacL11ΔIR4) in equine NBL-6 cells. Infected cells were harvested at 3, 6, 12, 18,
-6 cells.
Fig. 4.Weight loss or gain of CBA mice mock-infected or infected with EHV-1 RacL11BD
or RacL11ΔIR4 (IR4−/−). Mice were inoculated intranasally and weighed every 24 h for
96 h as described in the Materials and methods. Data points represent means of ten
mice; weight loss or gain was calculated in relation to the initial weight at the time of
infection. Error bars represent standard deviation. (⁎) P=44; (⁎⁎) Pb001.
Fig. 5.Western blot analysis of RK13 (A) and NBL-6 (B) cells infected with RacL11BD or
RacL11ΔIR4. Infected cells (MOI=1) were harvested at indicated times and probed with
antisera speciﬁc for the IE, UL5, EICP0, ETIF, and gD proteins. Rabbit gapdh or horse actin
was detected as loading controls.
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cells prompted the question as to whether the deletion of IR4 pro-
hibited EHV-1 replication in other cell types routinely used to cultivate
this alphaherpesvirus. To address this question, assays examining
the replication of RacL11BD and RacL11ΔIR4 were performed in
mammalian cell cultures representing a diversity of species, includ-
ing mouse L-M, rabbit RK13, non-human primate Vero, and human
HeLa cells. Whereas RacL11ΔIR4 titers were lower than those of
RacL11BD in equine NBL-6 cells as shown above (Fig. 3), the IR4
mutant virus failed to replicate in all other cell types tested (Table 2).
Expression of IR4 in RK13 cells by transient transfection resulted
in the recovery of viable RacL11ΔIR4 (Table 2), albeit at lower
levels than that recovered from NBL-6 cells. These results indicated
that replication of EHV-1 is severely restricted in the absence of IR4 in
many cell types normally permissive for EHV-1, and that ectopic
expression of IR4 in RK13 cells restores the ability of the IR4-null virus
to replicate.
Synthesis of some essential viral proteins is altered or abrogated in the
absence of IR4
To identify the nature of the block in the replication of the IR4-
null virus, RK13 cells infected with RacL11BD and RacL11ΔIR4
(MOI=1) were examined at various times post infection by western
blot analysis for the production of the IE protein and representative
early and late proteins. Production of the IE protein in cells infected
with the IR4-null mutant was indistinguishable from that observed
in cells infected with the parent virus (Fig. 5A). The early essential
regulatory protein UL5P (Fig. 5A) and the EHV-1 major DNA binding
protein (UL53P, data not shown) were likewise produced indepen-
dently of the presence of IR4 both in terms of kinetics and total
protein levels. In the absence of IR4, the synthesis of the early EICP0
protein, a potent transcriptional trans-activator (Bowles et al., 1997),
was found to be initially delayed but by 16 h post-infection reached
levels comparable to those in cells infected with the parent virus
(Fig 5A). Late viral protein production was examined usingTable 3
RacL11ΔIR4 fails to replicate in the lungs of CBA mice
Virus PFU titer determined in equine NBL6 cells
Inoculuma 2 days p.i.b 4 days p.i.b 6 days p.i.b
RacL11ΔIR4 5×105 b50 b50 b50
RacL11BD 5×105 4.6×106 2.6×105c 4.7×103d
a =pfu.
b =pfu/lung; n=5 mice per group.
c One mouse succumbed to infection.
d Two mice succumbed to infection. RacL11BD is parent RacL11 virus derived from
BAC.antibodies speciﬁc for glycoproteins D and K (gD, gK) and ORF12,
the EHV-1 trans-inducing factor (ETIF). Production of the essential
ETIF protein, which is synthesized at the initiation of viral DNA
replication, was both delayed and reduced in the absence of IR4
(Fig. 5A). Production of gD (Fig. 5A) and gK (data not shown), which
are both essential envelope proteins, was reduced to undetectable
levels in the non-permissive cell line, whereas gD production in
NBL-6 cells infected with RacL11ΔIR4 was detected, albeit at reduced
levels, after an initial delay (Fig. 5A and B). Examination of the pro-
duction of the EICP0 protein in infected NBL-6 cells at 2 and 8 h post
infection revealed no difference between RacL11BD and RacL11ΔIR4
(Fig. 5B).
Viral DNA synthesis is inhibited in RK13 cells in the absence of IR4
While analysis of non-permissive RK13 cells infected with
RacL11ΔIR4 revealed impaired synthesis of a number of important
viral proteins, the ability of the mutant virus to replicate DNA re-
mained in question. To address whether IR4 production is required
for viral DNA synthesis, real-time PCR was performed on samples
containing total DNA harvested from RK13 cells infected with either
RacL11BD or RacL11ΔIR4 at 2, 8, 12, 24, and 48 h post-infection. The
results were normalized to the cellular gapdh gene as an internal
control and expressed as the relative change in viral genomic copy
number after an initial 2 h time point. Compared to that of RacL11BD,
the replication of RacL11ΔIR4 DNA was inhibited in excess of 99.9%,
and the earliest detection of viral DNA replication was delayed by
16 h compared to RacL11BD (Fig. 6A). Interestingly, there was a 50%
reduction in RacL11ΔIR4 DNA copies detected at 8 h post-infection
which may indicate degradation of the mutant viral genome
following entry. While RacL11ΔIR4 also exhibited a lag in the
synthesis of viral DNA and, ultimately, viral DNA failed to reach
levels comparable to RacL11BD in permissive NBL-6 cells, the
inhibition of viral DNA synthesis was far less pronounced at late
times (Fig 6B). Severe cytopathology of cells infected with RacL11BD
Fig. 6. Comparison of viral DNA synthesis. RK13 (A) or NBL-6 (B) cells were infectedwith
RacL11BD or RacL11ΔIR4 and harvested at indicated times post-infection. Cell pellets
were prepared as described in Materials and Methods, and the relative change in viral
DNA copy number after 2 h was measured using real-time PCR. Samples were tested in
triplicate, and the results were normalized to total sample DNA. Extensive cytopathol-
ogy made testing of RacL11BD infected cells at 48 h impractical. Error bars indicate
standard deviation.
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point impractical.
Discussion
IR4 homologues have regulatory roles inmany alphaherpesviruses.
The HSV-1 homologue, ICP22, is thought to direct transcription away
from cellular promoters to viral promoters via hyper-phosphorylation
of RNA polymerase II (Rice et al., 1994, 1995; Leopardi et al., 1997).
Likewise, the ORF63/70 protein is thought to have a role in regulating
varicella-zoster virus (VZV) promoters, but its function is less clear
(Jackers et al., 1992; Kost et al., 1995). Discerning the role of the IR4
protein of EHV-1 based on characterized functions of its homologues
may be problematic, however, as the similarity among the different
proteins is, in many cases, quite low. Indeed, ICP22 of HSV-1 is a 420aa
immediate-early protein, whereas IR4 is 293aa and is an early
regulatory protein. Additionally, IR4 is diploid in EHV-1, while its
counterpart is haploid in HSV-1.
In HSV-1, ICP22 is not essential for virus growth in some cell types
(Post and Roizman 1981; Poffenberger et al.,1993, 1994, Orlando et al.,
2006). The VZV genome is structured more closely to that of EHV-1,
and in VZV one copy of the diploid IR4 homologue ORF63/70 is
required for virus replication (Sommer et al., 2001). EHV-1 deleted for
both copies of IR4 was able to replicate in non-immortalized equine
cells, although its growth kinetics were signiﬁcantly retarded in
comparison to those of the parent virus. It should be noted that while
the diploid nature of IR4 in EHV-1 made the generation of full IR4revertants unfeasible, the analysis of both BAC DNA and the properties
of the progeny viruses demonstrated that any unintended alterations
of the EHV-1 genome were unlikely, in agreement with the de-
monstration that IR4 produced in trans restored RacL11ΔIR4 replica-
tion in RK13 cells. Additionally, recent experiments succeeded in
generating an EHV-1 mutant virus devoid of the entire internal repeat
of the S region and indicated that one copy of IR4 is sufﬁcient to
support viral replication in RK13 cells that are non-permissive for
RacL11ΔIR4 (Ahn, Breitenbach, Zhang, and O'Callaghan, unpublished
results).
The ﬁndings that the infection of mice with the IR4-null virus
failed to cause clinical signs and to result in virus replication in the
mouse lung were not unexpected given the observation that the IR4-
null virus fails to replicate in murine cells in culture. The facts that the
IR4 mutant virus can be propagated in equine NBL-6 cells and is non
pathogenic in the mouse model that mimics EHV-1 infection in the
equine may be observations that could be exploited in future work
to develop vaccines and gene delivery vehicles for the equine. In
permissive NBL-6 cells, plaque morphology was indistinguishable in
the absence of IR4, and average plaque size was not signiﬁcantly
different in the absence of IR4. It is likely that the production of late
protein species, such as glycoprotein D, that mediate cell fusion and
inﬂuence plaque morphology is sufﬁcient by 72 h post-infection in
NBL-6 cells to yield similar plaque characteristics, even though overall
virus production is reduced in this cell type.
A recent report (Orlando et al., 2006) showed that deletion of
ICP22 results in HSV-1 particles that contain greatly reduced quan-
tities of the late proteins US11 and gC, produce increased amounts of
ICP0 and ICP4, and exhibits biochemical and physical properties that
are distinct from wt virus, resulting in a 500-fold decrease in
infectivity. In the case of EHV-1, it remains to be determined whether
non-infectious particles are produced in cells non-permissive for the
IR4-null virus. However, in these cells, the IEP protein and early
proteins UL5P and UL53P were produced in nearly identical amounts
and with similar kinetics in the presence or absence of IR4, indicating
that viral entry and the initiation of the viral replication cycle were not
impaired. Also, the inhibition of the synthesis of ETIF, recently shown
to be essential for EHV-1 secondary envelopment and virion matu-
ration (von Einem et al., 2006), and the complete inhibition of
synthesis of gD and gK, which are known to play essential roles in
maturation, egress, and infectivity, argue that EHV-1 replication in the
absence of IR4 is blocked at a stage prior to that of particle formation
and release. Since EHV-1 DNA replication is impaired in excess of three
logs in the absence of IR4 in non-permissive RK13 cells, future work
will be required to determine whether IR4 plays a direct role in DNA
replication and/or whether the IR4 protein is essential for transcribing
early genes required for DNA synthesis.
Materials and methods
Virus and cells
Pathogenic EHV-1 strain RacL11 was propagated in equine NBL-6
cells. Mouse L-M, rabbit RK-13, equine NBL-6, equine ETCC (Allen and
Bryans,1974), primate Vero, and humanHeLa cells were propagated in
Dulbecco's minimum essential medium (DMEM) supplemented with
5% or 10% fetal bovine serum (FBS), and selected cells were used in
transfections and infections as indicated.
Plasmids
pGexEuS4 containing full length EUs4 that encodes gp2 of EHV-1
(RacL11 strain) was generated by PCR ampliﬁcation of EUs4 and
surrounding sequences with primers incorporating BamHI and EcoRI
restriction sites. pSVIR4 (formerly pSVEICP22) has been previously
described. (Derbigny et al., 2000).
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An EHV-1 RacL11 BAC (Rudolph et al., 2002) was deleted for a
single copy of IR4 by RED recombination as previously described (Yao
et al., 2003). Brieﬂy, a kanamycin (KAN) resistance marker generated
by PCR using primers containing approximately 50 bp of IR4 ﬂanking
sequences in their 5′ ends was electroporated into E. coli DY380
(containing the EHV-1 BAC) previously grown at 42 °C to induce RED
recombinases. Electroporated cultures were inoculated onto medium
containing kanamycin (30 µg/mL) to select for transformants. The
second copy of IR4 was deleted in the same manner employing a
zeocin (ZEO) marker. Putative transformants were screened by: 1) PCR
ampliﬁcation of both EHV-1/antibiotic resistance marker junction
sequences and IR4 internal sequences; 2) Southern blot analysis using
probes speciﬁc for IR4 sequences, kanamycin (KAN) marker sequences,
or zeocin (ZEO) marker sequences; and 3) sequencing of EHV-1/
antibiotic resistance marker junctions.
Generation of IR4 null virus
Puriﬁed BAC constructs were electroporated (Nucleofector, Amaxa
Corp, Germany) into NBL-6 cells that were then incubated at 37 °C for
5–7 days. Supernatant was transferred to fresh NBL-6monolayers, and
cells were observed for cytopathic effects. Green ﬂuorescent plaques
were selected and puriﬁed three times. EUs4 revertant viruses were
generated by co-electroporating BAC constructs with pGexEUs4. In the
case of RacL11ΔIR4, cells transfected with the EUs4 restoration
plasmid were subsequently infected with the RacL11ΔIR4ΔEUs4
virus. In both cases, non-ﬂuorescing plaques were isolated and puri-
ﬁed three times. DNA was isolated from each putative revertant and
screened by PCR targeting full length EUs4.
Western blot analysis
RK13 or NBL-6 cells were seeded onto 60 mm tissue culture dishes
(BD Biosciences, Durham, NC) and infected the subsequent day at a
conﬂuency of 80–90% with either RacL11BD or RacL11ΔIR4 viruses.
Protein extracts of infected cells were separated by SDS-PAGE, elec-
trophoretically transferred to a nitrocellulose membrane (Bio-Rad
LSG, Hercules, CA), blocked in 1% skim milk, rinsed in Tris-Buffered
Saline (pH 7.4) with 0.5% Tween-20 (TBST), and incubated with the
indicated primary antibodies at a concentration of 1:2500 to 1:10,000.
The membranes were washed again and incubated with a 1:10,000
dilution of the secondary antibody (alkaline phosphatase-conjugated
goat anti-rabbit or anti-mouse antiserum; Sigma, St Louis, MO).
Protein-antibody complexes were visualized by incubating the
membranes in AP color reagent (Bio-Rad LSG, Hercules, CA) per the
manufacturer's instructions.
Growth kinetics and plaque morphology
NBL-6, RK-13, L-M, Vero, HeLa, ETCC, and pSVIR4 transfected RK-13
cells were seeded to 80% conﬂuence in 60 mm dishes and infected at
an MOI=1. Cells and supernatants were harvested at the indicated
times post-infection. Serial dilutions of each sample were used to
inoculate fresh NBL-6 monolayers. Monolayers were incubated in
medium containing 1.5% methylcellulose, and plaques were quanti-
tated after 3 days by ﬁxing with 10% formalin and staining with 0.5%
crystal violet.
Animal experiments
Groups (n=10) of three-week-old CBA mice were infected
intranasally with 5×105 pfu of RacL11ΔIR4 or RacL11BD, or were
mock-infected with sterile medium. Mice were weighed prior to
inoculation and every 24 h post-inoculation for 5 days. Differences inweight loss or gain over time were measured by comparing individual
mouse weight at each interval to weigh prior to inoculation. Virus
replication in mice was measured by infecting groups of 20 three-
week-old CBA mice as described above. Five mice from each group
were sacriﬁced at 4, 48, 96, and 144 h post-infection, and lungs were
harvested. Whole lungs were combined in diluent and homogenized,
and the virus concentration in each sample was quantitated as
previously described (Smith et al., 2005).
Real-time PCR analysis of viral DNA replication
RK13 cells were infected with RacL11ΔIR4 or RacL11BD as des-
cribed, and monolayers were harvested at 2, 8, 12, 24, and 48 h post-
infection. Cell pellets were resuspended in 500 µL of DNAzol (MRC,
Inc., Cincinnati, OH) and incubated at 100 °C for 5 min to ensure
release of DNA. The samples were then diluted by a factor of 100 and
stored at 20 °C until ready for use. Primers speciﬁc for gapdh (forward)
5′-TGC CCC CAT GTT TGT GAT G-3′ and (reverse) 5′-TGT GGT CAT GAG
CCC TTC C-3′ and primers speciﬁc for EHV-1 UL5 (forward) 5′-CAA
CTG GAA GCA GCA ACA GC-3′ and (reverse) 5′-GCG GTG AAC TCT GGC
CAC GC-3′were utilized to amplify viral and cellular DNA using an IQ5
real-time PCR instrument and IQ SYBR Green real-time PCR supermix
(Bio-Rad LSG, Hercules, CA). The relative change in genomic copy
number was extrapolated by determining threshold detection cycle
differences in viral DNA after 2 h and normalized against the cellular
gapdh gene as an internal control for total sample DNA.
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